Aldeyra Therapeutics, Inc. (ALDX)
0.91
-0.01
(-0.69%)
USD |
NASDAQ |
Oct 12, 16:00
0.91
0.00 (0.00%)
After-Hours: 16:51
Aldeyra Therapeutics Free Cash Flow (Quarterly) : -4.612M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.612M |
| March 31, 2026 | -5.110M |
| December 31, 2025 | -5.299M |
| September 30, 2025 | -7.021M |
| June 30, 2025 | -8.555M |
| March 31, 2025 | -12.47M |
| December 31, 2024 | -12.04M |
| September 30, 2024 | -7.975M |
| June 30, 2024 | -13.22M |
| March 31, 2024 | -9.973M |
| December 31, 2023 | 0.5004M |
| September 30, 2023 | -8.025M |
| June 30, 2023 | -13.36M |
| March 31, 2023 | -9.444M |
| December 31, 2022 | -11.23M |
| September 30, 2022 | -12.57M |
| June 30, 2022 | -19.96M |
| March 31, 2022 | -12.89M |
| December 31, 2021 | -11.58M |
| September 30, 2021 | -8.434M |
| June 30, 2021 | -9.072M |
| March 31, 2021 | -13.48M |
| December 31, 2020 | -8.317M |
| September 30, 2020 | -6.238M |
| June 30, 2020 | -7.579M |
| Date | Value |
|---|---|
| March 31, 2020 | -15.36M |
| December 31, 2019 | -11.23M |
| September 30, 2019 | -7.913M |
| June 30, 2019 | -12.82M |
| March 31, 2019 | -13.04M |
| December 31, 2018 | -7.940M |
| September 30, 2018 | -7.779M |
| June 30, 2018 | -6.308M |
| March 31, 2018 | -8.094M |
| December 31, 2017 | -5.198M |
| September 30, 2017 | -4.706M |
| June 30, 2017 | -5.312M |
| March 31, 2017 | -4.198M |
| December 31, 2016 | -3.910M |
| September 30, 2016 | -3.504M |
| June 30, 2016 | -3.256M |
| March 31, 2016 | -4.491M |
| December 31, 2015 | -3.019M |
| September 30, 2015 | -2.937M |
| June 30, 2015 | -1.632M |
| March 31, 2015 | -1.845M |
| December 31, 2014 | -1.615M |
| September 30, 2014 | -1.211M |
| June 30, 2014 | -0.8945M |
| March 31, 2014 | -1.064M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -181.32M |
| Oncolytics Biotech, Inc. | -8.066M |
| Sangamo Therapeutics, Inc. | -19.30M |
| Sarepta Therapeutics, Inc. | 196.52M |
| Anixa Biosciences, Inc. | -1.77M |